Imperial College London adult centre

This centre is a partnership between Imperial College London and Imperial College Healthcare NHS Trust. It’s internationally recognised for translating innovative cancer technologies and therapies.

Centre overview

Our Imperial College London adult experimental cancer medicine centre (ECMC) focuses on translational medical oncology, surgery and interventional science, cancer imaging and patient and public involvement. It also holds expertise in advanced imaging, metabolomics, surgical innovation and immunotherapy.

The centre is an international leader in treating prostate cancer, gynaecological, gestational trophoblastic, breast, haematologic and colorectal cancers.

Expertise

  • surgery and intervention science

  • early-phase clinical trials, including investigational medicinal product studies

  • imaging studies

  • gastrointestinal malignancies (upper and lower)

  • gynaecological cancers

  • urological cancers

Patient population

Between 2024-2025

4,619

4,619 new cancer cases within the NHS trust

50%

50% recruited onto clinical trials

Key contacts

Image of Iain McNeish.

Iain McNeish - Centre co-lead

Iain McNeish is a Professor of Oncology and Head of the Division of Cancer at Imperial College London. He directs the Ovarian Cancer Action Research Centre, co-leads Imperial NIHR Biomedical Research Centre’s Surgery and Cancer theme and chairs the Gynaecologic Cancer Intergroup for ovarian cancer. His research focuses on ovarian cancer, leading BriTROC and advancing novel therapies.

Image of Hashim Ahmed.

Hashim Ahmed - Centre co-lead

Hashim Ahmed, Chair of Urology at Imperial College London, is an expert in imaging, diagnosis and minimally invasive surgical techniques for treating prostate cancer. Hashim is also Section Lead for Speciality Surgery and Chair of the UK Prostate Cancer Research Strategy Group. His interests are in health technology assessment and novel trial designs that lead to changes in clinical practice.​

Image of Paul Craven.

Paul Craven - Centre business co-lead

Paul Craven is Director of Research Operations and leads the Imperial Joint Research Office. The office is responsible for managing and administering all research grants and contracts received by the two organisations, as well as the set-up and delivery of all clinical research studies in the Trust. Paul is responsible for the operational delivery of the NIHR Imperial Biomedical Research Centre.

Image of Naina Patel.

Naina Patel - Centre business co-lead

​​Naina Patel is the Cancer Research UK Core Resource Manager and manages the experimental cancer medicine centre/Imperial College Biomedical Research Centre Laboratory, which helps coordinate and perform translational work for early clinical cancer trials and studies. Her team provides biobanking, histology and biostatistical analyses for experimental cancer medicine centre-supported projects.

Image of Kelly Gleason.

Kelly Gleason - Patient and public involvement lead

Kelly Gleason is the Imperial Cancer Research UK Lead Nurse. She runs the Imperial Patient and Public Group for Cancer, an extensive group of 80 members. Kelly supports the patient representatives at Imperial by co-facilitating science communication workshops, participating in patient involvement training for students and staff and leading events.

Contact details

​​ECMC/ICBRC Laboratory, Division of Cancer

Imperial College London Hammersmith Campus, 2nd Floor, B-block (U201)

Du Cane Road

London

W12 0NN​

Programme office email:

ecmcadmin@cancer.org.uk

You might also be interested in

Latest news

Explore the latest articles, updates, interviews and news from our network.

Sign up to our newsletter

Be the first to hear about the latest network news, events and opportunities with our monthly newsletter.

Industry and partners

We are a centralised platform for commercial partners to launch trials quickly with access to expert teams, sites and processes.